Who should receive EGFR tyrosine-kinase inhibitors?
Overview
publication date
- October 16, 2012
published in
- The Lancet. Oncology Journal
Research
keywords
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Protein Kinase Inhibitors
- Quinazolines
Identity
Scopus Document Identifier
- 84868204421
Digital Object Identifier (DOI)
- 10.1016/S1470-2045(12)70434-5
PubMed ID
- 23078959
Additional Document Info
volume
- 13
issue
- 11